The term chronic obstructive pulmonary disease
|
|
- Nicholas Bridges
- 6 years ago
- Views:
Transcription
1 382Clinical Pharmacist December 2010 Vol 2 Chronic obstructive pulmonary disease is an incurable condition affecting millions of people worldwide. COPD clinical features and diagnosis By Hasanin Khachi, DipClinPharm, MRPharmS, Neil Barnes, FRCP, and Sotiris Antoniou, MSc, MRPharmS The term chronic obstructive pulmonary disease (COPD) was first coined by William Briscoe in It is an umbrella term used to describe a group of airways diseases that are not fully reversible, are predominantly caused by smoking and affect patients over 35 years of age. 2 COPD is a progressive, life-threatening condition that affects millions of people within the UK and worldwide. An understanding of the risk factors, symptoms and diagnostic measures are required to be able to manage this progressive disease effectively. Details of the pathophysiology of COPD can be found in Box 1 (p384). COPD is often undiagnosed it is estimated that only 900,000 out of three million people who have COPD in England have been diagnosed. 3 Globally, COPD is currently the fourth leading cause of death and the World Health Organization estimates that, by 2030, COPD will become the third leading cause of death. 4,5 In England and Wales, one person dies every 20 minutes as a result of COPD. It accounts for 1.4 million GP consultations and over 30,000 deaths in the UK each year. 5 COPD is the second most common cause of emergency admissions to hospital and the fifth largest cause of readmissions into hospital. 6 COPD results in over one million hospital bed days in England. 6 In the UK, direct care costs associated with COPD amount to 3bn per year, and the overall cost is 6.6bn annually. 6 SUMMARY Chronic obstructive pulmonary disease (COPD) is a term used to describe a group of airways diseases that are not fully reversible. COPD accounts for a large amount of morbidity and mortality and is expected to become the third leading cause of death worldwide by The symptoms of COPD include breathlessness, chronic cough and regular sputum production. Diagnosis should take these symptoms into account, in addition to exposure to risk factors such as cigarette smoke. The severity of COPD can be assessed using spirometry. Mortality may be better predicted using other measures. genetics and gender) and environmental factors (such as smoking and occupational exposure). 2,7 Smoking Tobacco smoke has been implicated in the development of chronic bronchitis and emphysema since the 1960s. 8 Tobacco smoke has numerous pulmonary effects, which include the release of destructive proteolytic enzymes from inflammatory cells in the lung, oxidative stress and inactivation of a1-antitrypsin (see Box 1, p384). Although it has been estimated that 15 20% of smokers develop COPD, recent evidence suggests that the actual proportion is 50%. 9 The risk of COPD developing in smokers is dose related and is affected by the age at which smoking started and the total pack-years smoked: Fred Goldstein Dreamstimes.com Risk factors The risk factors for COPD are not completely understood epidemiological studies have identified associations rather than cause and effect relationships. It is hypothesised that the risk of developing COPD is due to an interaction between host factors (such as Hasanin Khachi is highly specialist respiratory pharmacist, Neil Barnes is consultant respiratory physician and Sotiris Antoniou is principal pharmacist for cardiac and respiratory medicine, all at Barts and The London NHS Trust. E: hasanin.khachi@bartsandthelondon.nhs.uk
2 Vol 2 December 2010 Clinical Pharmacist 383 Number of cigarettes number of years Total pack years = smoked per day of smoking 20 Environmental exposure to tobacco smoke is also associated with reduced lung function. Maternal smoking has been shown to affect lung development in utero and is linked with reduced lung function among offspring in adulthood. 10,11 Passive smoking is also associated with reduced lung function, although this association is not as strong. The effect of smoking and smoking cessation on lung function is illustrated in Figure 1. Occupational dusts and chemicals Occupational dusts and chemicals have been recognised as co-factors for developing COPD and there is a relationship between the degree of lung impairment and the intensity and duration of exposure. Examples of implicated substances include organic and inorganic dusts, chemicals and fumes. 2,12 A survey involving almost 10,000 adult patients showed that occupational exposure caused 19.2% of COPD cases, with 31.1% having never smoked. 13 This is consistent with American Thoracic Society estimates of occupational exposure accounting for 10 20% of all COPD cases. 14,15 Indoor air pollution The burning of open fires of wood, animal dung, coal and agricultural residues (eg, for cooking and heating) can lead to high levels of indoor air pollution in poorly ventilated dwellings. The global population at risk of this form of COPD is three billion, with women in parts of the Middle East, Africa and Asia at particular risk. 16 This COPD risk factor currently causes 10 20% of all cases worldwide and results in two million deaths each year. 17 Genetics The best documented host factor for the development of COPD is the recessive, hereditary deficiency of a1-antitrypsin (Box 1, p384). Predominantly affecting people of northern European origin, a1- antitrypsin deficiency results in the early and accelerated development of panlobular emphysema in smokers and non-smokers, with the risk in smokers increasing exponentially. 18 Worldwide, a1-antitrypsin deficiency 2, 19 accounts for only a small number COPD cases. Other risk factors Other risk factors for the development of COPD include: Lung growth and development: a meta-analysis has shown a positive correlation between birth weight and forced expiratory volume in one second (FEV 1 ) 7, 20 (see Diagnosis below) in adulthood Gender: the role of gender in the development of COPD is unclear, although some studies have suggested that women are more susceptible to the effects of tobacco smoke than men. Previous studies had shown a greater prevalence and mortality among men than women; however more recent studies show that in developed countries the prevalence is now similar, probably as a result of women living longer and their changing patterns of smoking 2 Figure 1: Graph showing effect of smoking and smoking cessation on lung function Lung function (percentage of FEV1 value at age 25 years) 100% 75% 50% 25% 0% 25 THE RISK OF COPD DEVELOPING IN SMOKERS IS DOSE RELATED AND IS AFFECTED BY THE AGE AT WHICH SMOKING STARTED AND THE TOTAL PACK-YEARS SMOKED Susceptible smoker Disability Death Stopped at age 45 years Never smoked or not susceptible to smoke Stopped at age 65 years Age (years) Infection: a history of tuberculosis and childhood infections have both been associated with reduced lung function and airflow obstruction that predisposes to COPD in later life. 7,21 The development of pneumonia before two years of age has been shown to result in a mean loss in FEV 1 of 0.65L in males, and twice that figure when associated with lifelong smoking 22 Socioeconomic status: the risk of developing COPD is inversely associated with affluence. 23 Reasons are multifactorial and include greater smoking prevalence, poorer housing and poorer nutrition 23 Nutrition: a diet rich in fruit and vegetables is associated with a reduced risk of COPD 24 Asthma: the presence of asthma in adults results in a 12-fold increased risk of developing COPD. 25 Approximately 20% of asthmatics develop signs of irreversible airway limitation 26 Symptoms COPD is characterised primarily by the presence breathlessness, chronic cough and sputum production. However, the early stages of COPD are often asymptomatic and it is not until patients experience significant limitation that they seek medical advice. Breathlessness For patients, breathlessness (dyspnoea) is often the most concerning early symptom of COPD. It is persistent and progressive, and is usually worse with physical exertion. As the disease progresses, breathlessness becomes more problematic, even with minimal exertion or at rest. The Medical Research Council dyspnoea scale (see Box 2, p384), can be used to establish the extent of a patient s exertional breathlessness and can help to predict mortality in COPD. 2,27 In addition to defining the degree of dyspnoea-related disability associated with COPD, the MRC dyspnoea scale can also be used to determine at
3 384Clinical Pharmacist December 2010 Vol 2 Box 1: COPD pathophysiology Chronic obstructive pulmonary disease (COPD) is an umbrella term for a group of chronic respiratory diseases, including emphysema and chronic bronchitis. Emphysema Emphysema is a pathological process that involves the progressive and destructive enlargement of the bronchioles, alveolar ducts and alveolar sacs. This leads to loss of surfaces available for gas exchange and a loss of elastic recoil in the small airways. Elastic recoil is essential for maintaining the force of expiration its loss in emphysema can result in airways collapse, especially during expiration, which in turn leads to increased thoracic gas volume and hyperinflation in the lungs. There are two main types of emphysema: centrilobular and panacinar. Centrilobular emphysema is the most common form, characterised by the destruction of bronchioles, alveolar ducts and alveoli, and is more common in the upper lobes of lungs in cigarette smokers and coal miners. Panacinar emphysema is less common and is associated with deficiency of a1-antitrypsin a protease inhibitor that protects against lung damage. It is thought that the presence of oestrogen, which stimulates the synthesis of protease inhibitors such as a1-antitrypsin, confers protection in women. Chronic bronchitis Chronic bronchitis is defined as the presence of cough and sputum production for at least three months in each of two consecutive years. 2 It is an inflammatory process that occurs in the bronchi in response to inhaled irritants, usually due to cigarette smoking. This results in the accumulation and hypersecretion of mucous-secreting glands in the bronchial tree. Viral and bacterial infections can cause worsening of symptoms and exacerbations. Common bacterial infections can be caused by pathogens such as Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae. In advanced COPD, the impairment of gas diffusion can lead to hypoxaemia (low oxygen), hypercapnia (increased carbon dioxide) and pulmonary hypertension, with resultant vascular remodelling, increased right-ventricular pressure and subsequent right-ventricular failure, known as cor pulmonale. Peripheral oedema in cor pulmonale is mediated by the physiological changes that occur following hypoxaemia and hypercapnia. These include activation of the renin-angiotensin system, salt and water retention and a reduction in renal blood flow. Although patients with emphysema experience greater dyspnoea than patients with bronchitis, they are better able to preserve gas exchange (because, unlike bronchitis, the ventilation-to-perfusion ratio is maintained) and thus are less likely to develop cor pulomale and polycythaemia (increased red blood cells) at an early stage. which stage pulmonary rehabilitation would be costeffective and indicated (see p393 of accompanying article). Pulmonary rehabilitation is indicated for patients admitted to hospital following a COPD exacerbation or for patients with an MRC score of 3 or higher. Chronic cough Chronic cough is one of the earliest symptoms of COPD. Cough can be productive or unproductive and initially occurs intermittently, becoming more frequent as the disease progresses. Unlike breathlessness, chronic cough usually occurs at the earliest stage of COPD and is often discounted by patients as a sign of ageing or lack of physical fitness. Sputum Regular production of sputum in three or more months over two consecutive years defines the presence of chronic bronchitis. 2 However, sputum purulence in COPD patients varies considerably (in terms of quantity and colour, which may depend on the underlying causes of COPD) and is difficult to evaluate accurately due to differing patient habits with sputum (some patients will swallow rather than expectorate). A change in colour or volume of sputum may signify the early signs of an exacerbation of COPD. Other symptoms Wheeze and chest tightness can occur at any stage of COPD, but usually occurs in severe COPD. 2 More frequent winter colds or winter bronchitis and fatigue are also common among those with COPD. Diagnosis A diagnosis of COPD should be considered in patients over the age of 35 years who have a risk factor such as smoking and who display one or more of the symptoms described above. 28 The diagnosis should take into account the patient s medical history and previous exposure to risk factors for the disease. Airflow obstruction can be measured accurately using spirometry, and this should be performed at the time of diagnosis, with specific reference to the following measures: 2,28 Box 2: Medical Research Council dyspnoea scale 27 GRADE DEGREE OF BREATHLESSNESS RELATED TO ACTIVITIES 1 Not troubled by breathlessness except on strenuous exercise 2 Short of breath when hurrying or walking up a slight hill 3 Walks slower than contemporaries on level ground because of breathlessness, or has to stop for breath when walking at own pace 4 Stops for breath after walking about 100 metres or after a few minutes on level ground 5 Too breathless to leave the house, or breathless when dressing or undressing FEV 1 : volume of air that the patient is able to expel in the first second (expressed in litres and as a percentage of the predicted value) Forced vital capacity (FVC): total volume of air that the patient can forcibly exhale in one breath (expressed in litres and as a percentage of the predicted value) FEV 1 /FVC: the ratio of FEV 1 to FVC A post-bronchodilator FEV 1 /FVC ratio <0.7 confirms the presence of COPD. 2,28 If the FEV 1 is ³80% of predicted, a diagnosis of COPD should only be made in the presence of other respiratory symptoms such as breathlessness or chronic cough. 28
4 386Clinical Pharmacist December 2010 Vol 2 Similarities with asthma COPD and asthma may have some overlapping symptoms but can be distinguished based on the patient s history, exposure to risk factors and spirometry results. Box 3 shows the clinical features differentiating COPD and asthma. It is worth noting that, in patients with chronic asthma, the distinction with COPD is sometimes difficult to make and it is assumed that asthma and COPD can co-exist in such patients. 2 Reversibility testing If COPD diagnosis is in doubt, reversibility testing can help to distinguish the presence of COPD or another underlying respiratory disease such as asthma. Since COPD is characterised by airflow obstruction that is not fully reversible, 28 reversibility testing using an inhaled bronchodilator (eg, salbutamol) can be used to distinguish between COPD and asthma. Minor degrees of reversibility have no prognostic value, but a marked post-bronchodilator response greater than 400ml suggests the presence of asthma. 28 Severity The severity of COPD can be classified according to the patient s FEV 1 compared with predicted values (see below). However, it should be borne in mind that severity based on FEV 1 may not always correspond to the degree of symptom control and exacerbation rates. Disease severity is an indicator of prognosis. The fiveyear survival of patients with mild COPD is 78% for men and 72% for women. 29 This reduces to 30% and 24%, respectively, for patients with severe disease. 29 Unsurprisingly, the economic impact of COPD also correlates with severity, with the annual cost for a patient Coloured X-ray of the lungs of a patient with chronic obstructive pulmonary disease with mild COPD estimated at 120 compared with over 3,000 for a patient with severe COPD. 5 According to the National Institute for Health and Clinical Excellence and the Global Initiative for Chronic Obstructive Lung Disease, patients with a postbronchodilator FEV 1 /FVC ratio below 0.7 can be classified as follows: 2,28 Scott Camazine Science Photo Library Box 3: Differences between asthma and COPD 28 FEATURES COPD ASTHMA Smoker or ex-smoker Nearly all Possibly Symptoms under age 35 years Rare Often Chronic productive cough Common Uncommon Breathlessness Night-time waking with breathlessness or wheeze Significant diurnal or day-to-day variability of symptoms VARIABLE Box 4: The BODE index 28 Persistent and progressive Uncommon Uncommon Variable Common Common POINTS ON THE BODE INDEX FEV 1 (% of ³ predicted) Distance walked in ³ six minutes (m) Modified Medical Research Council dyspnoea scale Body mass index >21 21 FEV 1 ³80%: stage 1 (mild) FEV %: stage 2 (moderate) FEV %: stage 3 (severe) FEV 1 <30%: stage 4 (very severe) Some studies have found that an index known as BODE is a better predictor of exacerbations, hospital admission and mortality than FEV BODE is an acronym for: Body mass index Obstruction (degree of airway obstruction): measured as a percentage of predicted FEV 1 Dyspnoea: measured using a modified MRC dyspnoea scale Exercise tolerance: measured with a six-minute walk test The BODE index is a 10-point scoring system, with a higher score corresponding with a higher likelihood for poor patient outcomes. (Box 4 shows how points on the BODE index are allocated.) The updated NICE guidelines suggest that the BODE index should be used to assess the prognosis of all patients. The BODE index can be modified to a BOD index if there is difficulty carrying out an exercise tolerance test. The severity of COPD will also guide treatment (see accompanying article, p390).
5 Vol 2 December 2010 Clinical Pharmacist 389 References 1 Petty TL. The history of COPD. International Journal of COPD 2006:1; Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (accessed 29 October 2010). 3 World Health Organization. Chronic respiratory diseases. respiratory/copd/burden/en/index.html (accessed 29 October 2010). 4 Hospital Episodes Statistics. Met Office health forecasts for COPD patients. (accessed 29 October 2010). 5 Department of Health. On the state of the public health: annual report of the chief medical officer July (accessed 29 October 2010). 6 British Thoracic Society. The burden of lung disease. June (accessed 29 October 2010). 7 Chapman KR, Mannino DM, Soriano JB, et al. Epidemiology and costs of chronic obstructive pulmonary disease. European Respiratory Journal 2006;27: Hoogendoorn M, Rutten-van Mölken MP, Hoogenveen RT, et al. A dynamic population model of disease progression in chronic obstructive pulmonary disease. European Respiratory Journal 2005;26: Lundbäck B, Lindberg A, Lindström M, et al. Not 15 but 50% of smokers develop COPD? Report from the obstructive lung disease in Northern Sweden studies. Respiratory Medicine 2003;97: Barker DJP. Chronic bronchitis. In: Mothers, babies and disease in later life. London: BMJ Publishing Group, 1994; pp Tager IB, Ngo L, Hanrahan JP. Maternal smoking during pregnancy. Effects on lung function during the first 18 months of life. American Journal of Respiratory and Critical Care Medicine 1995;152: Isoaho R, Puoluoki H, Huhti E, et al. Prevalence of chronic obstructive pulmonary disease in elderly Finns. Respiratory Medicine 1994;88: Hnizdo E, Sullivan PA, Bang KM, et al. Association between chronic obstructive pulmonary disease and employment by industry and occupation in the US population: a study of data from the Third National Health and Nutrition Examination Survey. American Journal of Epidemiology 2002;156: Trupin L, Earnest G, San Pedro M, et al. The occupational burden of chronic obstructive pulmonary disease. European Respiratory Journal 2003;22: Balmes J, Becklake M, Blanc P, et al. American Thoracic Society statement: occupational contribution to the burden of airway disease. American Journal of Respiratory and Critical Care Medicine 2003;167: Chan-Yeung M, Ait-Khaled N, White N, et al. The burden and impact of COPD in Asia and Africa. International Journal of Tuberculosis and Lung Disease 2004;8: Smith K. Pollution management in focus. Washington DC: The World Bank; Blanco I, de Serres FJ, Fernandez-Bustillo E, et al. Estimated numbers and prevalence of PI*S and PI*Z alleles of alpha1-antitrypsin deficiency in European countries. European Respiratory Journal 2006;27: Sandford AJ, Weir TD, Paré PD. Genetic risk factors for chronic obstructive pulmonary disease. European Respiratory Journal 1997;10: Lawlor DA, Ebrahim S, Davey Smith G. Association of birth weight with adult lung function: findings from the British Women's Heart and Health Study and a meta-analysis. Thorax 2005;60: Menezes AM, Hallal PC, Perez-Padilla R, et al. Tuberculosis and airflow obstruction: evidence from the PLATINO study in Latin America. European Respiratory Journal 2007;(6): Shaheen SO, Barker DJP, Shiell AW, et al. The relationship between pneumonia in early childhood and impaired lung function in late adult life. American Journal of Respiratory Critical Care Medicine 1994;149: Prescott E, Lange P, Vestbo J. Socioeconomic status, lung function and admission to hospital for COPD: results from the Copenhagen City Heart Study. European Respiratory Journal 1999;13: Watson L, Margetts B, Howarth P, et al. The association between diet and chronic obstructive pulmonary disease in subjects selected from general practice. European Respiratory Journal 2002;20: Silva GE, Sherrill DL, Guerra S, et al. Asthma as a risk factor for COPD in a longitudinal study. Chest 2004;126: Vonk JM, Jongepier H, Panhuysen CI, et al. Risk factors associated with the presence of irreversible airflow limitation and reduced transfer coefficient in patients with asthma after 26 years of follow up. Thorax 2003;58: Bestall JC, Paul EA, Garrod R, et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999;54: National Institute for Health and Clinical Excellence. Management of chronic obstructive pulmonary disease in adults in primary and secondary care. June (accessed 29 October 2010). 29 Soriano JB, Maier WC, Egger P, et al. Recent trends in physician diagnosed COPD in women and men in the UK. Thorax 2000;55: Ong KC, Earnest A, Lu SJ. A multidimensional grading system (BODE index) as predictor of hospitalization for COPD. Chest 2005;128: Marin JM, Carrizo SJ, Casanova C, et al. Prediction of risk of COPD exacerbations by the BODE index. Respiratory Medicine 2009;103: Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. New England Journal of Medicine 2004;350:
JOINT CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) MANAGEMENT GUIDELINES
JOINT CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) MANAGEMENT GUIDELINES Authors Dr Ian Benton Respiratory Consultant COCH Penny Rideal Respiratory Nurse COCH Kirti Burgul Respiratory Pharmacist COCH Pam
More informationPeople with asthma who smoke. The combination of asthma, a chronic airway disease, and smoking increases the risk of COPD even more.
COPD Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory lung disease that causes obstructed airflow from the lungs. Symptoms include breathing difficulty, cough, sputum (phlegm) production
More informationCOPD/ Asthma. Dr Heather Lewis Honorary Clinical Lecturer
COPD/ Asthma Dr Heather Lewis Honorary Clinical Lecturer Objectives To understand the pathogenesis of asthma/ COPD To recognise the clinical features of asthma/ COPD To know how to diagnose asthma/ COPD
More informationan inflammation of the bronchial tubes
BRONCHITIS DEFINITION Bronchitis is an inflammation of the bronchial tubes (or bronchi), which are the air passages that extend from the trachea into the small airways and alveoli. Triggers may be infectious
More informationDifferential diagnosis
Differential diagnosis The onset of COPD is insidious. Pathological changes may begin years before symptoms appear. The major differential diagnosis is asthma, and in some cases, a clear distinction between
More informationBode index as a predictor of severity in patients with chronic obstructive pulmonary disease.
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 15, Issue 5 Ver. VII (May. 2016), PP 93-100 www.iosrjournals.org Bode index as a predictor of severity
More informationChronic obstructive lung disease. Dr/Rehab F.Gwada
Chronic obstructive lung disease Dr/Rehab F.Gwada Obstructive lung diseases Problem is in the expiratory phase Lung disease Restrictive lung disease Restriction may be with, or within the chest wall Problem
More informationCOPD. Helen Suen & Lexi Smith
COPD Helen Suen & Lexi Smith What is COPD? Chronic obstructive pulmonary disease: a non reversible, long term lung disease Characterized by progressively limited airflow and an inability to perform full
More informationReference Guide for Group Education
A p l a n o f a c t i o n f o r l i f e Reference Guide for Group Education Session 1 Introduction to Living Well with COPD Education Program Participants Expectations Towards the Program Health in COPD
More informationCOPD. Breathing Made Easier
COPD Breathing Made Easier Catherine E. Cooke, PharmD, BCPS, PAHM Independent Consultant, PosiHleath Clinical Associate Professor, University of Maryland School of Pharmacy This program has been brought
More informationCHRONIC OBSTRUCTIVE PULMONARY DISEASE
CHRONIC OBSTRUCTIVE PULMONARY DISEASE DEFINITION Chronic obstructive pulmonary disease (COPD) is a common preventable and treatable disease characterized by airflow limitation that is usually progressive
More informationChronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary Disease 07 Contributor Dr David Tan Hsien Yung Definition, Diagnosis and Risk Factors for (COPD) Differential Diagnoses Goals of Management Management of COPD THERAPY AT EACH
More informationUNDERSTANDING COPD MEDIA BACKGROUNDER
UNDERSTANDING COPD MEDIA BACKGROUNDER What is COPD? Chronic Obstructive Pulmonary Disease (COPD) also called emphysema and/or chronic obstructive bronchitis* is a preventable lung disease caused by the
More informationCOPD Management in LTC: Presented By: Jessica Denney RRT
COPD Management in LTC: Presented By: Jessica Denney RRT Sponsored by Z & D Medical Services, Diamond Sponsor Seizing Opportunities to Provide Individualized Treatment and Device Selection for your COPD
More informationThe role of lung function testing in the assessment of and treatment of: AIRWAYS DISEASE
The role of lung function testing in the assessment of and treatment of: AIRWAYS DISEASE RHYS JEFFERIES ARTP education Learning Objectives Examine the clinical features of airways disease to distinguish
More informationChronic Obstructive Pulmonary Disease (COPD) Measures Document
Chronic Obstructive Pulmonary Disease (COPD) Measures Document COPD Version: 3 - covering patients discharged between 01/10/2017 and present. Programme Lead: Jo Higgins Clinical Lead: Dr Paul Albert Number
More informationChronic obstructive pulmonary disease
0 Chronic obstructive pulmonary disease Implementing NICE guidance June 2010 NICE clinical guideline 101 What this presentation covers Background Scope Key priorities for implementation Discussion Find
More informationCOPD and environmental risk factors other than smoking. 14. Summary
COPD and environmental risk factors other than smoking 14. Summary Author : P N Lee Date : 7 th March 2008 1. Objectives and general approach The objective was to obtain a good insight from the available
More informationCourse Handouts & Disclosure
COPD: Disease Trajectory and Hospice Eligibility Terri L. Maxwell PhD, APRN VP, Strategic Initiatives Weatherbee Resources Hospice Education Network Course Handouts & Disclosure To download presentation
More informationChronic Obstructive Pulmonary Disease (COPD).
Chronic Obstructive Pulmonary Disease (COPD). Linde: Living healthcare 02 03 Chronic Obstructive Pulmonary Disease (COPD). A pocket guide for healthcare professionals. COPD the facts Moderate to severe
More informationPulmonary Pathophysiology
Pulmonary Pathophysiology 1 Reduction of Pulmonary Function 1. Inadequate blood flow to the lungs hypoperfusion 2. Inadequate air flow to the alveoli - hypoventilation 2 Signs and Symptoms of Pulmonary
More informationLife-long asthma and its relationship to COPD. Stephen T Holgate School of Medicine University of Southampton
Life-long asthma and its relationship to COPD Stephen T Holgate School of Medicine University of Southampton Definitions COPD is a preventable and treatable disease with some significant extrapulmonary
More information2/4/2019. GOLD Objectives. GOLD 2019 Report: Chapters
GOLD Objectives To provide a non biased review of the current evidence for the assessment, diagnosis and treatment of patients with COPD. To highlight short term and long term treatment objectives organized
More informationChronic Obstructive Pulmonary Disease (COPD) Clinical Guideline
Chronic Obstructive Pulmonary Disease (COPD) Clinical These clinical guidelines are designed to assist clinicians by providing an analytical framework for the evaluation and treatment of patients. They
More informationEmphysema. Lungs The lungs help us breathe in oxygen and breathe out carbon dioxide. Everyone is born with 2 lungs: a right lung and a left lung.
Emphysema Introduction Emphysema is a type of chronic obstructive pulmonary disease, or COPD. COPD affects millions of people worldwide. Emphysema involves damage to the air sacs in the lungs. This makes
More informationLecture Notes. Chapter 4: Chronic Obstructive Pulmonary Disease (COPD)
Lecture Notes Chapter 4: Chronic Obstructive Pulmonary Disease (COPD) Objectives Define COPD Estimate incidence of COPD in the US Define factors associated with onset of COPD Describe the clinical features
More informationCOPD and other lung conditions
COPD and other lung conditions COPD COPD is an umbrella term used to describe a collection of lung diseases including emphysema and chronic bronchitis. C Chronic - long term condition O Obstructive - difficulty
More informationCOPD GOLD Guidelines & Barnet inhaler choices. Dr Dean Creer, Respiratory Consultant, Royal Free London NHS Foundation Trust
COPD GOLD Guidelines & Barnet inhaler choices Dr Dean Creer, Respiratory Consultant, Royal Free London NHS Foundation Trust GOLD 2017 Report: Chapters 1. Definition and Overview 2. Diagnosis and Initial
More informationUpdate on heterogeneity of COPD, evaluation of COPD severity and exacerbation
Update on heterogeneity of COPD, evaluation of COPD severity and exacerbation Yung-Yang Liu, MD Taipei Veterans General Hospital Aug 29, 2015 G O lobal Initiative for Chronic bstructive L D ung isease
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Chronic obstructive pulmonary disease: the management of adults with chronic obstructive pulmonary disease in primary and secondary
More informationCOPD COPD. C - Chronic O - Obstructive P - Pulmonary D - Disease OBJECTIVES
COPD C - Chronic O - Obstructive P - Pulmonary D - Disease 1 OBJECTIVES Following this presentation the participant should be able to demonstrate understanding of chronic lung disease by successful completion
More informationRoflumilast (Daxas) for chronic obstructive pulmonary disease
Roflumilast (Daxas) for chronic obstructive pulmonary disease August 2009 This technology summary is based on information available at the time of research and a limited literature search. It is not intended
More informationRESPIRATORY CARE IN GENERAL PRACTICE
RESPIRATORY CARE IN GENERAL PRACTICE Definitions of Asthma and COPD Asthma is due to inflammation of the air passages in the lungs and affects the sensitivity of the nerve endings in the airways so they
More informationRESPIRATORY PHYSIOLOGY Pre-Lab Guide
RESPIRATORY PHYSIOLOGY Pre-Lab Guide NOTE: A very useful Study Guide! This Pre-lab guide takes you through the important concepts that where discussed in the lab videos. There will be some conceptual questions
More informationOverview of Obstructive Diseases of the Lung, Lung Physiology and Imaging Modalities
Overview of Obstructive Diseases of the Lung, Lung Physiology and Imaging Modalities Jann Mortensen Final Phil meeting, 29 april 2004 Obstructive disease Definition Epidemiologi Mechanisms Natural history
More informationChronic Obstructive Pulmonary Disease (COPD) Copyright 2014 by Mosby, an imprint of Elsevier Inc.
Chronic Obstructive Pulmonary Disease () 8.18.18 Copyright 2014 by Mosby, an imprint of Elsevier Inc. Description Airflow limitation not fully reversible progressive Abnormal inflammatory response of lungs
More informationChronic obstructive pulmonary disease
Chronic obstructive pulmonary disease By: Dr. Fatima Makee AL-Hakak () University of kerbala College of nursing Out lines What is the? Overview Causes of Symptoms of What's the difference between and asthma?
More informationSession Guidelines. This is a 15 minute webinar session for CNC physicians and staff
Respiratory Disease Session Guidelines This is a 15 minute webinar session for CNC physicians and staff CNC holds webinars monthly to address topics related to risk adjustment documentation and coding
More informationSelf-management plan for COPD
Sheffield Clinical Commissioning Group Sheffield Teaching Hospitals NHS Foundation Trust Self-management plan for COPD This is your personal management plan The aim of the plan is to help you have better
More informationDisclosure and Conflict of Interest 8/15/2017. Pharmacist Objectives. At the conclusion of this program, the pharmacist will be able to:
Digging for GOLD Rebecca Young, PharmD, BCACP, Roosevelt University College of Pharmacy Assistant Professor of Clinical Sciences Practice Site Advocate Medical Group-Nesset Pavilion Disclosure and Conflict
More informationChronic Obstructive Pulmonary Disease
Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory lung disease that causes obstructed airflow from the lungs. Symptoms include breathing difficulty, cough, sputum (phlegm) production
More informationUnconscious exchange of air between lungs and the external environment Breathing
Respiration Unconscious exchange of air between lungs and the external environment Breathing Two types External Exchange of carbon dioxide and oxygen between the environment and the organism Internal Exchange
More informationCommunity COPD Service Protocol
Community COPD Service Protocol Acknowledgements This protocol is based on the following documents: 1. Chronic obstructive pulmonary disease: Management of chronic obstructive pulmonary disease in adults
More informationOverview of COPD INTRODUCTION
Overview of COPD INTRODUCTION Chronic obstructive pulmonary disease (COPD) is a common lung disease that affects millions of people, and it is the fourth leading cause of death in the United States. It
More informationPDF of Trial CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Wed, 31 Oct 2018 11:13:48 GMT) CTRI Number Last Modified On 17/01/2015 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study
More informationSTOP SMOKING with Nicotine Replacement Therapy
STOP SMOKING with Nicotine Replacement Therapy Gita Anjali Shah, Clinical Pharmacist, UK and Guest Lecturer, Faculty of Pharmacy, Mahidol University Shocking Statistics According to the last Global Adult
More informationThe development of chronic obstructive pulmonary
THE PATHOGENESIS AND PATHOLOGY OF COPD: IDENTIFYING RISK FACTORS AND IMPROVING MORBIDITY AND MORTALITY * Paul D. Scanlon, MD ABSTRACT Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory
More informationAsthma COPD Overlap (ACO)
Asthma COPD Overlap (ACO) Dr Thomas Brown Consultant Respiratory Physician Thomas.Brown@porthosp.nhs.uk Dr Hitasha Rupani Consultant Respiratory Physician Hitasha.rupani@porthosp.nhs.uk What is Asthma
More informationKnown Allergies: Shellfish. Symptoms: abdominal pain, nausea, diarrhea, or vomiting. congestion, trouble breathing, or wheezing.
CSTAR CASE STUDIES: BLOCK B Asthma or COPD? Setting: Walk in clinic. Dan: I havi g that cough thi g agai HPI: Dan is a 49-year-old male teacher who reports having had episodes of cough with mucus production
More informationBasic mechanisms disturbing lung function and gas exchange
Basic mechanisms disturbing lung function and gas exchange Blagoi Marinov, MD, PhD Pathophysiology Department, Medical University of Plovdiv Respiratory system 1 Control of breathing Structure of the lungs
More informationSelf-Management Plan for COPD
Self-Management Plan for COPD This is your personal management plan. The aim of this plan is to help you have better control of your chronic obstructive pulmonary disease (COPD). It will enable you to
More informationDefining COPD. Georgina Grantham Community Respiratory Team Leader/ Respiratory Nurse Specialist
Defining COPD Georgina Grantham Community Respiratory Team Leader/ Respiratory Nurse Specialist Defining COPD Chronic Obstructive Pulmonary Disease (COPD) is a common, preventable and treatable disease
More informationAdvances in Chronic Obstructive Pulmonary Disease
Advances in Chronic Obstructive Pulmonary Disease By Dave C. Todd, MD; and Darcy D. Marciniuk, MD, FRCPC The case of Nina Nina, 64, presents to the clinic with a three- to fouryear history of progressive,
More informationPulmonary Function Testing: Concepts and Clinical Applications. Potential Conflict Of Interest. Objectives. Rationale: Why Test?
Pulmonary Function Testing: Concepts and Clinical Applications David M Systrom, MD Potential Conflict Of Interest Nothing to disclose pertinent to this presentation BRIGHAM AND WOMEN S HOSPITAL Harvard
More informationAmerican Thoracic Society (ATS) Perspective
National Surveillance System for Chronic Lung Disease (CLD): American Thoracic Society (ATS) Perspective Gerard J. Criner, M.D. Chronic Obstructive Pulmonary Disease (COPD) l Definition: Group of chronic
More informationASTHMA-COPD OVERLAP SYNDROME 2018: What s All the Fuss?
ASTHMA-COPD OVERLAP SYNDROME 2018: What s All the Fuss? Randall W. Brown, MD MPH AE-C Association of Asthma Educators Annual Conference July 20, 2018 Phoenix, Arizona FACULTY/DISCLOSURES Randall Brown,
More informationCOPD. Dr.O.Paknejad Pulmonologist Shariati Hospital TUMS
IN THE NAME OF GOD COPD Dr.O.Paknejad Pulmonologist Shariati Hospital TUMS Definition of COPD* COPD is a preventable and treatable chronic lung disease characterized by airflow limitation that is not fully
More informationEndobronchial valve insertion to reduce lung volume in emphysema
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Interventional procedure consultation document Endobronchial valve insertion to reduce lung volume in emphysema Emphysema is a chronic lung disease that
More informationCOPD is a syndrome of chronic limitation in expiratory airflow encompassing emphysema or chronic bronchitis.
1 Definition of COPD: COPD is a syndrome of chronic limitation in expiratory airflow encompassing emphysema or chronic bronchitis. Airflow obstruction may be accompanied by airway hyper-responsiveness
More informationChronic inflammation of the airways Hyperactive bronchi Shortness of breath Tightness in chest Coughing Wheezing
Chronic inflammation of the airways Hyperactive bronchi Shortness of breath Tightness in chest Coughing Wheezing Components of the respiratory system Nasal cavity Pharynx Trachea Bronchi Bronchioles Lungs
More informationReferring for specialist respiratory input. Dr Melissa Heightman Consultant respiratory physician, UCLH,WH, CNWL
Referring for specialist respiratory input Dr Melissa Heightman Consultant respiratory physician, UCLH,WH, CNWL Respiratory Specialist- who? GPSI Community Team Secondary Care Respiratory physician and
More informationChapter Effects of Smoke on the Respiratory System Part 2 pages
Chapter 18.1 Effects of Smoke on the Respiratory System Part 2 pages 417-419 Hemoglobin has 4 separate protein chains. Each protein chain has a single iron atom (Fe 3+ ). Each iron atom can bind to a single
More informationexacerbation has greater impact on functional status than frequency of exacerbation episodes.
Original Article Singapore Med J 2011, 52(12) 894 Changes in the BODE index, exacerbation duration and hospitalisation in a cohort of COPD patients Bu X N, Yang T, Thompson M A, Hutchinson A F, Irving
More informationRESPIRATORY DISORDERS
RESPIRATORY DISORDERS INTRODUCTION Respiratory disorders refers to the medical term that include different pathological conditions affecting the organs and tissues of respiratory system which make gas
More informationChronic Obstructive Pulmonary Disease A breathtaking condition
1. Jan Crouch JC 2. Diane Cruikshank DC 3. Jillian Millar Drysdale JMD 4. Medical Editor 5. Robert Clarke Article: COPD & smoking.doc Section: Growing Older Family Health: Fall 2008 Chronic Obstructive
More informationMedicine Dr. Kawa Lecture 1 Asthma Obstructive & Restrictive Pulmonary Diseases Obstructive Pulmonary Disease Indicate obstruction to flow of air
Medicine Dr. Kawa Lecture 1 Asthma Obstructive & Restrictive Pulmonary Diseases Obstructive Pulmonary Disease Indicate obstruction to flow of air through the airways. As asthma, COPD ( chronic bronchitis
More informationIntegrated Cardiopulmonary Pharmacology Third Edition
Integrated Cardiopulmonary Pharmacology Third Edition Chapter 13 Pharmacologic Management of Asthma, Chronic Bronchitis, and Emphysema Multimedia Directory Slide 7 Slide 12 Slide 60 COPD Video Passive
More informationPomPom SHOOTER. Activity Background: Common Obstructive Lung Disorders:
CAUTION: Students with asthma or other respiratory problems should NOT perform the breathing exercises in this activity because they involve repeated maximal inhalations and exhalations and use of a breathing
More informationThis is a cross-sectional analysis of the National Health and Nutrition Examination
SUPPLEMENTAL METHODS Study Design and Setting This is a cross-sectional analysis of the National Health and Nutrition Examination Survey (NHANES) data 2007-2008, 2009-2010, and 2011-2012. The NHANES is
More informationCOPD: early detection, screening and case-finding: what is the evidence? Prof. Jan-Willem Lammers, Md PhD Department of Respiratory Diseases
COPD: early detection, screening and case-finding: what is the evidence? Prof. Jan-Willem Lammers, Md PhD Department of Respiratory Diseases «If you test one smoker with cough every day You will diagnose
More informationAsthma and COPD in older people lumping or splitting? Christine Jenkins Concord Hospital Woolcock Institute of Medical Research
Asthma and COPD in older people lumping or splitting? Christine Jenkins Concord Hospital Woolcock Institute of Medical Research Concord Hospital Woolcock Institute of Medical Research Joe has asthma What
More informationCOPD in Korea. Division of Pulmonary, Allergy and Critical Care Medicine of Hallym University Medical Center Park Yong Bum
COPD in Korea Division of Pulmonary, Allergy and Critical Care Medicine of Hallym University Medical Center Park Yong Bum Mortality Rate 1970-2002, USA JAMA,2005 Global Burden of Disease: COPD WHO & World
More informationInterventional procedures guidance Published: 20 December 2017 nice.org.uk/guidance/ipg600
Endobronchial valve insertion to reduce lung volume in emphysema Interventional procedures guidance Published: 20 December 2017 nice.org.uk/guidance/ipg600 Your responsibility This guidance represents
More informationGuideline for the Diagnosis and Management of COPD
Guideline for the Diagnosis and Management of COPD Introduction Chronic obstructive pulmonary disease (COPD) is a respiratory disorder largely caused by smoking. It is characterized by progressive, partially
More informationSGRQ Questionnaire assessing respiratory disease-specific quality of life. Questionnaire assessing general quality of life
SUPPLEMENTARY MATERIAL e-table 1: Outcomes studied in present analysis. Outcome Abbreviation Definition Nature of data, direction indicating adverse effect (continuous only) Clinical outcomes- subjective
More informationChronic Obstructive Pulmonary Disease Guidelines and updates
Chronic Obstructive Pulmonary Disease Guidelines and updates October 20, 2018 Saratoga Springs, NY COPD (Chronic obstructive pulmonary disease) is a major cause of mortality and morbidity in the United
More informationChronic obstructive pulmonary disease in over 16s: diagnosis and management
National Institute for Health and Care Excellence Draft for consultation Chronic obstructive pulmonary disease in over 16s: diagnosis and management [D] Diagnosing COPD and predicting outcomes NICE guideline
More informationParamedic Rounds. Pre-Hospital Continuous Positive Airway Pressure (CPAP)
Paramedic Rounds Pre-Hospital Continuous Positive Airway Pressure (CPAP) Morgan Hillier MD Class of 2011 Dr. Mike Peddle Assistant Medical Director SWORBHP Objectives Outline evidence for pre-hospital
More informationYour Lungs and COPD. Patient Education Pulmonary Rehabilitation. A guide to how your lungs work and how COPD affects your lungs
Patient Education Your Lungs and COPD A guide to how your lungs work and how COPD affects your lungs Your lungs are organs that process every breath you take. They provide oxygen (O 2 ) to the blood and
More informationSilica dust and COPD, is there an association?
Silica dust and COPD, is there an association? K. Ulm Institute for Medical Statistics and Epidemiology University of Technology, Munich Germany 1 Outline: - what is COPD? - some fact about COPD - what
More informationBiochemistry of Lungs. Lecture # 35 Lecturer: Alexander Koval
Biochemistry of Lungs Lecture # 35 Lecturer: Alexander Koval Introduction Biochemistry of lungs Overview of substances produced (surfactant, mucus, collagen), inactivated (ROS, kinins, serotonin, catecholamines)
More informationT he recent international guidelines from the Global
842 CHRONIC OBSTRUCTIVE PULMONARY DISEASE Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study A Johannessen, E R Omenaas, P
More informationA cross sectional study assessing severity and systemic involvement in chronic obstructive pulmonary disease by bode index and gold classification
Original article: A cross sectional study assessing severity and systemic involvement in chronic obstructive pulmonary disease by bode index and gold classification 1Dr. Pramod Thakral, 2 Dr. Sivaranjani
More informationSelf-Management Plan for COPD
Self-Management Plan for COPD This is your personal management plan. The aim of this plan is to help you have better control of your chronic obstructive pulmonary disease (COPD). It will enable you to
More informationLiving well with COPD
This factsheet aims to show people with chronic obstructive pulmonary disease (COPD) and their friends and family how they can live a full life with this disease. What is COPD? COPD is a condition that
More informationNotes to complete gas exchange in mammals
Notes to complete gas exchange in mammals Mass flow of air to respiratory surface this is achieved through the mechanics of ventilation (breathing). This ensures a regular supply of air into and out of
More informationCOPD in primary care: reminder and update
COPD in primary care: reminder and update Managing COPD continues to be a major feature of primary care, particularly in practices with a high proportion of M ori and Pacific peoples. COPDX clinical practice
More informationHASPI Medical Anatomy & Physiology 14b Lab Activity
HASPI Medical Anatomy & Physiology 14b Lab Activity Name(s): Period: Date: Respiratory Distress Respiratory distress is a broad medical term that applies to any type of breathing difficulty and the associated
More informationCOPD: Change in Definition. COPD Pathology with 3D Interactive. COPD: Definitions of 21st Century 1. COPD Includes Chronic Bronchitis 2
COPD: Change in Definition COPD Pathology with 3D Interactive by Scott Cerreta, BS, RRT Director of Education www.copdfoundation.org COPD used to include 5 disease processes 1 1 Chronic Bronchitis 2 Emphysema
More informationInternal medicine. Lec #: 4 Date: COPD-Definition
Internal medicine Topic: COPD Dr: mousa malkawy Lec #: 4 Date: 26-10-2009 COPD-Definition A disease state characterized by airflow limitation that is not fully reversible and usually it is progressive
More informationChronic Obstructive Pulmonary Disease (COPD)
Chronic Obstructive Pulmonary Disease (COPD) Health Promotion and Education Program Rev. 2014 2014, MMM Healthcare, Inc. - PMC Medicare Choice, Inc. Reproduction of this material is prohibited. MP-HEP-PPT-200-01-021914-E
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
DRAFT NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Chronic obstructive pulmonary disease: the management of adults with chronic obstructive pulmonary disease in primary
More informationRespiratory Pathology. Kristine Krafts, M.D.
Respiratory Pathology Kristine Krafts, M.D. Normal lung: alveolar spaces Respiratory Pathology Outline Acute respiratory distress syndrome Obstructive lung diseases Restrictive lung diseases Vascular
More informationPATHOPHYSIOLOGICAL PROCESS TEMPLATE
1 PATHOPHYSIOLOGICAL PROCESS TEMPLATE DISEASE: Chronic obstructive pulmonary disease (COPD) DEFINITION: COPD can be defined as a disease in which there is a significant damage to the lungs thus reducing
More informationChronic obstructive pulmonary disease
Chronic obstructive pulmonary disease Abstract Whittaker C, BPharm, MRPharmS Amayeza Info Centre Chronic obstructive pulmonary disease affects millions of people, has a major impact on quality of life
More informationHow to treat COPD? What is the mechanism of dyspnea? Smoking cessation
: The Increasing Role of the FP Alan Kaplan, MD, CCFP(EM) Presented at the Primary Care Today: Education Conference and Medical Exposition, Toronto, Ontario, May 2006. Chronic obstructive pulmonary disease
More informationRe-Screening Medical History Questionnaire
Building Trades National Medical Screening Program Re-Screening Medical History Questionnaire Name: Address: _ City: _State: Zip Phone Number (include Area Code): Social Security # Date of Birth If female,
More informationAlpha-1 Antitrypsin Deficiency Alpha-1 Lung Disease
Alpha-1 Antitrypsin Deficiency Alpha-1 Lung Disease Chronic obstructive pulmonary disease (COPD) affects millions of people each year. Chronic means long term, obstructive means it is hard to get air in
More informationFunction of the Respiratory System. Exchange CO2 (on expiration) for O2 (on inspiration)
Function of the Respiratory System Exchange CO2 (on expiration) for O2 (on inspiration) Upper Respiratory Tract Includes: Nose Mouth Pharynx Larynx Function: Warms and humidifies the inspired air Filters
More informationChronic Obstructive Pulmonary Disease
Page 1 of 5 Chronic Obstructive Pulmonary Disease Chronic Obstructive Pulmonary Disease (COPD) is an 'umbrella' term for people with chronic bronchitis, emphysema, or both. With COPD the airflow to the
More information